IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 0.105 EUR -99.63% Market Closed

Market Cap: €8.1B

I	ImmunoGen Inc F:IMU	US
W	Wharf Holdings Ltd F:WHA	HK
T	Tencent Holdings Ltd F:NNND	CN
L	Live Nation Entertainment Inc F:3LN	US
R	Riwi Corp F:5RW	CA
	JPMorgan Chase & Co F:CMC	US
P	Paccar Inc F:PAE	US
B	Benefit Systems SA WSE:BFT	PL

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

75% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-108%

Operating Margin is Increasing

-199% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-107%

Net Margin is Increasing

-199% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-143%

Free Cash Flow Margin is Increasing

-218% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-298%

ROIC is Increasing

-582% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.